4Dhalla NS,Temsah RM,Netticadan T.Role of oxidative stress in cardiovascular diseases [J].J Hypertens,2000,18(6):655-673.
5Andona P,Karne R,Ghanim H,et al.Carvedilol inhibites reaction oxygen species generation by leukocytes and oxidative damage to amino acids[J].Circulation,2000,101:122-124.
6Oettl K,Greilberger J,Zangger K,et al.Radical-scavenging and iron-chelating properties of carvedilol,an antihypertensive drug with antioxiodative activity[J].Biochem Pharmacol,2001,62(2):241-248.
7Cargnoni A,Ceconi C,Bernocehi P,et al.Reduction of oxidative stress by carvedilol:role in maintenance of ischaemic myocardium viability[J].Cardiovasc Res,2000,47(3):556-566.
8Oliveira PJ,Coxito PM,Rolo AP,et al.Inhibitory effect of carvedilol in the high-conductance state of the mitochondrial permeability transition pore [J].Eur J Pharmacol,2001,412(3):231-237.
9Matsuda Y,Akita H,Terashima M,et al.Carvedilol improves endomelium-dependent dilatation in patients with coronary artery disease[J].Am Heart J,2000,140(5):753-759.
10Jones SP,Girod WG,Palazzo AJ,et al.Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase[J].Am J Physiol,1999,276(5Pt2):H1567-H1573.
